GRAIL is a healthcare company pioneering early cancer detection through a multi-cancer blood test. By analyzing DNA methylation patterns, it identifies cancer signals before symptoms appear. Patients benefit from earlier diagnoses, while doctors gain a powerful screening tool. Ultimately, GRAIL aims to reduce cancer mortality by transforming how the disease is detected.
Get alerts when this topic surges in newsletters. Free to start.
Sign up freeExplore more trends:Trending Topics ·AI Trends ·Business Trends ·Finance Trends ·Technology Trends